Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of ...

The term “heart failure” sounds as if the heart has stopped working. Although it’s a serious condition and requires timely medical attention, the words actually mean that the heart isn’t able to keep ...

Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...

The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to each patient's needs. Chris Bell, an acute care nurse practitioner who specializes ...

Bhubaneswar: The Kalinga Institute of Medical Sciences (KIMS) here has become the first in Odisha to introduce the ...

Joanne Matos, 37, was born with an enlarged heart and has congestive heart failure. Despite a stroke and two silent heart ...

Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients ...

The artificial intelligence model predicts patients’ heart disorders and risk of future heart failure using just an ...

Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...